Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development 2024-11-21 23:46
I-Mab to Participate at the Piper Sandler Healthcare Conference 2024-11-21 20:00
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024 2024-11-21 18:30
111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024 2024-11-21 18:00
InxMed FAK Inhibitor Ifebemtinib Received Breakthrough Therapy Designation by China National Medical Products Administration for First-Line Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation 2024-11-21 15:09
DP Technology and Lepu Biopharma Announce Milestone Collaboration: Leveraging Advanced Computational Methods to Accelerate ADC Drug Innovation 2024-11-21 13:01
Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias 2024-11-21 06:00
GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for Drug Products 2024-11-21 01:00
Laekna Announces a Clinical Collaboration with Lilly to Develop LAE102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2A for The Treatment of Obesity 2024-11-20 22:00
CABIO Deepens Commitment to Global Markets, Aiming to Serve International Clients and Pursue Long-Term International Partnerships 2024-11-20 21:00
2024 Global Healthy Longevity Conference Successfully Held 2024-11-20 19:13
Samsung Biologics signs manufacturing deal with European pharmaceutical company 2024-11-20 07:23
Epigenic Therapeutics to Enter Clinical Development of EPI-003: A First-in-Class Epigenetic Inactivator for the Treatment of Chronic Hepatitis B 2024-11-20 07:20
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson's Research Through Development of Next Generation Biomarker Assays 2024-11-19 22:12
Ractigen Therapeutics Announces FDA Orphan Drug Designation for RAG-21 for the Treatment of ALS 2024-11-19 21:26
Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study 2024-11-19 20:30
Brii Bio Delivers First Head-to-Head Comparison of siRNA (Elebsiran) and PEG-IFNα Combination versus PEG-IFNα Alone at AASLD's The Liver Meeting® 2024, Demonstrating Higher Loss of HBV Surface Antigen by Combining with siRNA 2024-11-19 19:30
SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player 2024-11-19 08:00
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline 2024-11-19 06:24
C Ray Therapeutics Completes Over $100 Million Series A+ Financing, Jointly Led by SCGC and TaiLong Capital 2024-11-18 22:00
1 2 3 4 5 451